Published in Yonsei Med J on December 18, 2009
Efficacy of immunosuppression monotherapy after liver transplantation: a meta-analysis. World J Gastroenterol (2014) 1.40
Hand transplants and the mandate for tolerance. Curr Opin Organ Transplant (2014) 0.78
Transplant Tolerance Induction in Newborn Infants: Mechanisms, Advantages, and Potential Strategies. Front Immunol (2016) 0.75
Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24
Weaning of immunosuppression in living donor liver transplant recipients. Transplantation (2001) 2.18
Weaning of immunosuppression in liver transplant recipients. Transplantation (1997) 1.57
Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation. Pediatr Transplant (2004) 1.49
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. J Hepatol (2006) 1.40
An appraisal of tolerance in liver transplantation. Am J Transplant (2006) 1.32
Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol (2006) 1.28
Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant (2003) 1.21
Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology (1998) 1.21
Endothelial cell chimerism does not influence allograft tolerance in liver transplant patients after withdrawal of immunosuppression. Transplantation (2003) 1.08
Tolerance: is it worth the risk? Transplantation (2005) 1.03
The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation. Am J Transplant (2005) 1.01
Risks and benefits of weaning immunosuppression in liver transplant recipients: long-term follow-up. Transplant Proc (1997) 0.92
All liver recipients benefit from the protocol 10-year liver biopsies. Hepatology (2003) 0.87
Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients. Transplantation (2001) 0.79
Immunosuppression withdrawal for treatment of severe infections in liver transplantation. Transplant Proc (1998) 0.79
Exposure rate of hydroxyapatite orbital implants a 15-year experience of 802 cases. Ophthalmology (2007) 2.35
Infliximab "Top-Down" Strategy is Superior to "Step-Up" in Maintaining Long-Term Remission in the Treatment of Pediatric Crohn Disease. J Pediatr Gastroenterol Nutr (2015) 2.12
Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr (2006) 1.83
Biology of hepatocellular carcinoma. Ann Surg Oncol (2008) 1.78
Donor morbidity including biliary complications in living-donor liver transplantation: single-center analysis of 827 cases. Transplantation (2012) 1.60
Delayed hemorrhage after pancreaticoduodenectomy. J Am Coll Surg (2004) 1.59
Safety of small-for-size grafts in adult-to-adult living donor liver transplantation using the right lobe. Liver Transpl (2010) 1.59
Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol (2005) 1.57
Comparison of the tolerance of hepatic ischemia/reperfusion injury in living donors: macrosteatosis versus microsteatosis. Liver Transpl (2014) 1.50
[Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea]. Korean J Gastroenterol (2009) 1.48
The hepatic regeneration power of mild steatotic grafts is not impaired in living-donor liver transplantation. Liver Transpl (2005) 1.45
Effect of infliximab top-down therapy on weight gain in pediatric Crohns disease. Indian Pediatr (2012) 1.39
Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes. J Lipid Res (2007) 1.37
Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy. BMC Cancer (2009) 1.31
Predicting survival after surgical resection for pancreatic ductal adenocarcinoma. Pancreas (2006) 1.25
Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis. J Clin Gastroenterol (2008) 1.17
Solid pseudopapillary tumor of the pancreas: a multicenter study of 23 pediatric cases. J Pediatr Surg (2006) 1.16
The changes in coagulation profile and epidural catheter safety for living liver donors: a report on 6 years of our experience. Liver Transpl (2007) 1.10
Hepatocyte transplantation for glycogen storage disease type Ib. Cell Transplant (2007) 1.07
Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma. Am J Surg (2006) 1.03
Antifibrotic effect of Pirfenidone on orbital fibroblasts of patients with thyroid-associated ophthalmopathy by decreasing TIMP-1 and collagen levels. Invest Ophthalmol Vis Sci (2010) 1.01
In situ induction of dendritic cell-based T cell tolerance in humanized mice and nonhuman primates. J Exp Med (2011) 1.01
Prolonged cold ischemic time is a risk factor for biliary strictures in duct-to-duct biliary reconstruction in living donor liver transplantation. Transplantation (2008) 1.01
Living donor liver transplantation using a graft from a donor with situs inversus totalis. Liver Transpl (2009) 0.99
Proteomic analysis of a ferric uptake regulator mutant of Helicobacter pylori: regulation of Helicobacter pylori gene expression by ferric uptake regulator and iron. Proteomics (2004) 0.99
The effect of alkaline phosphatase and intrahepatic metastases in large hepatocellular carcinoma. World J Surg Oncol (2013) 0.99
Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling. Ann Surg Oncol (2013) 0.98
Eotaxin and FGF enhance signaling through an extracellular signal-related kinase (ERK)-dependent pathway in the pathogenesis of Eosinophilic esophagitis. Allergy Asthma Clin Immunol (2010) 0.97
Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation. Transplantation (2014) 0.96
Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease. Immunol Lett (2005) 0.96
Correlation between fasting plasma ghrelin levels and age, body mass index (BMI), BMI percentiles, and 24-hour plasma ghrelin profiles in Prader-Willi syndrome. J Clin Endocrinol Metab (2004) 0.95
HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma. Ann Surg Oncol (2014) 0.94
Biliary reconstruction using the cystic duct in right lobe living donor liver transplantation. J Am Coll Surg (2004) 0.93
Clinical characteristics and prognosis of orbital invasive aspergillosis. Ophthal Plast Reconstr Surg (2008) 0.93
Intralesional injection of OK-432 for vision-threatening orbital lymphangioma. Graefes Arch Clin Exp Ophthalmol (2007) 0.92
Human B cell development and antibody production in humanized NOD/SCID/IL-2Rγ(null) (NSG) mice conditioned by busulfan. J Clin Immunol (2010) 0.92
Human T cell development in the liver of humanized NOD/SCID/IL-2Rγ(null)(NSG) mice generated by intrahepatic injection of CD34(+) human (h) cord blood (CB) cells. Clin Immunol (2011) 0.92
Initial location determines spontaneous passage of foreign bodies from the gastrointestinal tract in children. Pediatr Emerg Care (2011) 0.91
Propofol versus Midazolam for Sedation during Esophagogastroduodenoscopy in Children. Clin Endosc (2013) 0.91
Risk factor stratification after simultaneous liver and colorectal resection for synchronous colorectal metastasis. Langenbecks Arch Surg (2007) 0.91
Pediatric liver transplantation outcomes in Korea. J Korean Med Sci (2013) 0.91
Experience with laparoscopic-assisted anorectal pull-through in 25 males with anorectal malformation and rectourethral or rectovesical fistulae: postoperative complications and functional results. J Pediatr Surg (2013) 0.90
Differences between hepatocellular carcinoma and hepatitis B virus infection in patients with and without cirrhosis. Ann Surg Oncol (2013) 0.90
C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion. World J Surg Oncol (2013) 0.90
Co-Infection with Cytomegalovirus and Helicobacter pylori in a Child with Ménétrier's Disease. Pediatr Gastroenterol Hepatol Nutr (2013) 0.90
Clinical usefulness of human cytomegalovirus antigenemia assay after kidney transplantation. Transplantation (2003) 0.89
Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired. Surgery (2006) 0.89
Efficacy of early treatment with infliximab in pediatric Crohn's disease. World J Gastroenterol (2010) 0.89
Angiosarcoma arising within a long-standing cystic lesion of the adrenal gland: a case report. J Clin Oncol (2013) 0.88
Is colonoscopy necessary in children suspected of having colonic polyps? Gut Liver (2010) 0.88
High hilar dissection: new technique to reduce biliary complication in living donor liver transplantation. Liver Transpl (2004) 0.88
Intra-osseous injection of donor mesenchymal stem cell (MSC) into the bone marrow in living donor kidney transplantation; a pilot study. J Transl Med (2013) 0.87
Outcome of donors with a remnant liver volume of less than 35% after right hepatectomy. Liver Transpl (2006) 0.87
Intrathecal morphine combined with intravenous patient-controlled analgesia is an effective and safe method for immediate postoperative pain control in live liver donors. Liver Transpl (2009) 0.87
Regional cerebral glucose metabolic abnormality in Prader-Willi syndrome: A 18F-FDG PET study under sedation. J Nucl Med (2006) 0.87
Minimal proteinuria one year after transplant is a risk factor for graft survival in kidney transplantation. J Korean Med Sci (2009) 0.87
Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation. Liver Transpl (2014) 0.86
Immunocytochemical localization of zinc transporter 3 in the ependyma of the mouse spinal cord. Neurosci Lett (2003) 0.86
Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver. J Surg Oncol (2014) 0.86
The efficacy of clinical strategies to reduce nosocomial sepsis in extremely low birth weight infants. J Korean Med Sci (2005) 0.85
Hepatoblastoma: 15-year experience and role of surgical treatment. J Korean Surg Soc (2011) 0.85
Outcome of multipair donor kidney exchange by a web-based algorithm. J Am Soc Nephrol (2007) 0.85
ZnO/CuO heterojunction branched nanowires for photoelectrochemical hydrogen generation. ACS Nano (2013) 0.85
Recurrence of hepatocellular carcinoma after liver transplantation: patterns and prognostic factors based on clinical and radiologic features. AJR Am J Roentgenol (2007) 0.85
Histopathology and expression of Ki-67 and cyclooxygenase-2 in childhood Helicobacter pylori gastritis. J Gastroenterol (2004) 0.85
The expression of iron-repressible outer membrane proteins in Helicobacter pylori and its association with iron deficiency anemia. Helicobacter (2009) 0.85
Trend and outcome of Korean patients receiving overseas solid organ transplantation between 1999 and 2005. J Korean Med Sci (2010) 0.85
Long-term results of biliary atresia in the era of liver transplantation. Pediatr Surg Int (2013) 0.84
Allergic proctitis and abdominal distention mimicking Hirschsprung's disease in infants. Acta Paediatr (2007) 0.84
Paclitaxel-coated expanded polytetrafluoroethylene haemodialysis grafts inhibit neointimal hyperplasia in porcine model of graft stenosis. Nephrol Dial Transplant (2006) 0.84
Safety of the Use of Blood Salvage and Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma. Ann Surg (2016) 0.84
The lipopolysaccharide-triggered mesangial transcriptome: Evaluating the role of interferon regulatory factor-1. Kidney Int (2005) 0.84
Primary intestinal lymphangiectasia successfully treated by segmental resections of small bowel. J Pediatr Surg (2009) 0.84
Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients - a prospective study. Transpl Int (2008) 0.84
Prognosis for patients in a Korean population with ocular adnexal lymphoproliferative lesions. Ophthal Plast Reconstr Surg (2007) 0.84
Infliximab therapy in children with Crohn's disease: a one-year evaluation of efficacy comparing 'top-down' and 'step-up' strategies. Acta Paediatr (2011) 0.84
A therapeutic strategy for metastatic malignant fibrous histiocytoma through mesenchymal stromal cell-mediated TRAIL production. Ann Surg (2013) 0.84
Recurrence and treatment pattern in long-term survivors with hepatocellular carcinoma: a comparison between radiofrequency ablation and surgery as a first-line treatment. World J Surg (2010) 0.83
HCC in living donor liver transplantation: can we expand the Milan criteria? Dig Dis (2007) 0.83
Serum obestatin/ghrelin ratio is altered in patients after distal gastrectomy. Dig Surg (2009) 0.83
Hepatitis B virus vaccine switch program for prevention of de novo hepatitis B virus infection in pediatric patients. Transpl Int (2008) 0.83
Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl (2007) 0.83
ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor. J Hepatol (2013) 0.83
Is cytomegalovirus infection dangerous in cytomegalovirus-seropositive recipients after liver transplantation? Liver Transpl (2011) 0.83
Effects of AG490 on lens epithelial cell death induced by H(2)O(2). Jpn J Ophthalmol (2010) 0.83